Women’s health is a critical but sometimes overlooked healthcare segment, which has translated into women being underdiagnosed, undertreated and even given the wrong treatment regimens.
The PRISM Women’s Health Index tracks small and micro-cap stocks that focus on women’s health concerns; including breast cancer, cervical cancer, menopause and birth control.
| PRISM Women’s Health IndexInception Date of 1/2/2024 at $100.00 | % Change (Daily) | Current Index Value | % Change (Inception) | |||||
|---|---|---|---|---|---|---|---|---|
| -0.37% | $121.50 | 21.50% | ||||||
| Index Components | Ticker | Current Price | % Daily Change | Volume (1,000s) | Average Volume (1,000s) | Market Cap (Millions) | 1/2/2024 Price | % Change Since Inception 1/2/2024 |
| TherapeuticsMD, Inc. | TXMD | $2.00 | -0.99% | 43 | 39 | $23 | $2.33 | -14.16% |
| Establishment Labs Holdings Inc. | ESTA | $63.85 | -2.21% | 438 | 618 | $1,879 | $26.59 | 140.13% |
| PDS Biotechnology Corporation | PDSB | $1.07 | 1.91% | 5,463 | 754 | $60 | $5.15 | -79.22% |
| Sera Prognostics, Inc. | SERA | $2.07 | 0.98% | 1 | 53 | $79 | $5.97 | -65.33% |
| Verastem, Inc. | VSTM | $8.27 | 6.65% | 3,928 | 2,647 | $726 | $8.30 | -0.36% |
| Agile Therapeutics, Inc. | AGRX | $1.51 | 3.42% | 119 | 143 | $10 | $1.84 | -17.93% |
| Lipocine Inc. | LPCN | $2.20 | 4.76% | 105,178 | 89 | $18 | $2.86 | -23.08% |
| Dare Bioscience, Inc. | DARE | $0.79 | -5.17% | 113 | 412 | $12 | $0.33 | 140.19% |
| Nuvectis Pharma, Inc. | NVCT | $20.29 | 1.30% | 121 | 284 | $538 | $8.29 | 144.75% |
| Femasys Inc. | FEMY | $2.00 | -3.85% | 80 | 69 | $6 | $1.01 | 98.02% |
| INVO Fertility, Inc. | IVF | $0.74 | -7.24% | 162 | 2,445 | $1 | $0.78 | -5.13% |
| biote Corp. | BTMD | $1.11 | -2.63% | 195 | 278 | $49 | $6.20 | -82.10% |
| DiaMedica Therapeutics Inc. | DMAC | $7.99 | -1.72% | 221 | 0 | $431 | $5.56 | 43.71% |
